TherapeuticsMD (TXMD) Tax Rate (2011 - 2025)
TherapeuticsMD's (TXMD) quarterly Tax Rate came in at 4.79% in Q1 2025, up 133.63% quarter-over-quarter from 2.05% in Q3 2022.
Powered by 
Analysis
TherapeuticsMD (TXMD) Tax Rate (2011 - 2025) Analysis & Trends
TherapeuticsMD (TXMD) has reported Tax Rate for 3 consecutive years, with 4.79% the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Tax Rate changed N/A year-over-year to 4.79%; the trailing twelve-month figure through Sep 2025 stood at 3320.0% (changed N/A YoY), and the FY2024 full-year result was 1.32%, up 77.0% from the prior year.
- Tax Rate improved to 4.79% in Q1 2025 per TXMD's latest filing, from 2.05% in the prior quarter.
- Across five years, Tax Rate topped out at 4.79% in Q1 2025 and bottomed at 4.03% in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 62.33% |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 18.84% |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -31.96% |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 24.15% |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 4.79% |
| Sep 30, 2022 | 2.05% |
| Jun 30, 2022 | -4.03% |
| Sep 30, 2011 | -0.29% |